Biohaven Pharmaceutical Holding (BHVN) stock forecast for 2024

The forecast has been updated: June 2, 2023 9:28


Biohaven Pharmaceutical Holding stock price online today

Analyst Target Price

25

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell Biohaven Pharmaceutical Holding stock stock today? What is the projected target price level for 2024? How much will it cost in 2024? Biohaven Pharmaceutical Holding stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2024.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $25 target price for Biohaven Pharmaceutical Holding stock stock.

Today 200 Day Moving Average is the support level (14.53 $).

50 Day Moving Average is the support level (14.04 $).




BHVN Forecast for 2024

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 24.94 23.77 26.78 11.27 %
Feb 24.04 22.19 25.31 12.33 %
Mar 24.91 22.77 26.61 14.42 %
Apr 22.77 20.87 23.78 12.22 %
May 21.62 20.12 22.10 8.93 %
Jun 21.31 20.54 22.49 8.65 %
Jul 20.77 19.20 21.87 12.22 %
Aug 21.57 21.05 22.40 6.04 %
Sep 22.71 21.54 23.91 9.93 %
Oct 22.44 20.46 23.92 14.45 %
Nov 24.68 23.49 26.07 9.90 %
Dec 25.74 24.61 26.93 8.62 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Biohaven Pharmaceutical Holding stock.


Biohaven Pharmaceutical Holding overview

Biohaven Pharmaceutical Holding Address

215 CHURCH STREET, NEW HAVEN, CT, US

Market Capitalization

1 194 620 000 $

EBITDA

-524 956 000

PE Ratio

None

PEG Ratio

None

Dividend Per Share

0

Dividend Yield

0

EPS

-8.36

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

0

Trailing PE

-

Forward PE

-

EV To Revenue

-

EV To EBITDA

-2.412

52 Week High

21.25

52 Week Low

5.54

50 Day Moving Average

14.04

200 Day Moving Average

14.53

Shares Outstanding

68225000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

Biohaven Pharmaceutical Holding stock forecast for this year


Biohaven Pharmaceutical Holding stock forecast for Jan 2024.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 24.94. Negative monthly dynamics of the instrument is expected with 11.269% volatility is expected.

Pessimistic forecast: 23.77

Optimistic: 26.78


Biohaven Pharmaceutical Holding stock forecast for Feb 2024.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 24.04. Negative monthly dynamics of the instrument is expected with 12.329% volatility is expected.

Pessimistic forecast: 22.19

Optimistic: 25.31


Biohaven Pharmaceutical Holding stock forecast for Mar 2024.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 24.91. Positive monthly dynamics of the instrument is expected with 14.417% volatility is expected.

Pessimistic forecast: 22.77

Optimistic: 26.61


Biohaven Pharmaceutical Holding stock forecast for Apr 2024.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 22.77. Negative monthly dynamics of the instrument is expected with 12.222% volatility is expected.

Pessimistic forecast: 20.87

Optimistic: 23.78


Biohaven Pharmaceutical Holding stock forecast for May 2024.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 21.62. Negative monthly dynamics of the instrument is expected with 8.933% volatility is expected.

Pessimistic forecast: 20.12

Optimistic: 22.10


Biohaven Pharmaceutical Holding stock forecast for Jun 2024.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 21.31. Negative monthly dynamics of the instrument is expected with 8.654% volatility is expected.

Pessimistic forecast: 20.54

Optimistic: 22.49


Biohaven Pharmaceutical Holding stock forecast for Jul 2024.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 20.77. Negative monthly dynamics of the instrument is expected with 12.225% volatility is expected.

Pessimistic forecast: 19.20

Optimistic: 21.87


Biohaven Pharmaceutical Holding stock forecast for Aug 2024.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 21.57. Positive monthly dynamics of the instrument is expected with 6.037% volatility is expected.

Pessimistic forecast: 21.05

Optimistic: 22.40


Biohaven Pharmaceutical Holding stock forecast for Sep 2024.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 22.71. Positive monthly dynamics of the instrument is expected with 9.926% volatility is expected.

Pessimistic forecast: 21.54

Optimistic: 23.91


Biohaven Pharmaceutical Holding stock forecast for Oct 2024.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 22.44. Negative monthly dynamics of the instrument is expected with 14.446% volatility is expected.

Pessimistic forecast: 20.46

Optimistic: 23.92


Biohaven Pharmaceutical Holding stock forecast for Nov 2024.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 24.68. Positive monthly dynamics of the instrument is expected with 9.895% volatility is expected.

Pessimistic forecast: 23.49

Optimistic: 26.07


Biohaven Pharmaceutical Holding stock forecast for Dec 2024.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 25.74. Positive monthly dynamics of the instrument is expected with 8.622% volatility is expected.

Pessimistic forecast: 24.61

Optimistic: 26.93



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 101.66 (07.06.2023) -0.94 %
AbbVie Inc.
ABBV 136.5 (07.06.2023) 0.79 %
Aeterna Zentaris Inc.
AEZS 2.92 (06.06.2023) 3.18 %
Allakos Inc.
ALLK 4.85 (07.06.2023) -1.82 %
Allogene Therapeutics, Inc.
ALLO 5.84 (07.06.2023) -0.68 %
Amgen Inc.
AMGN 221.25 (07.06.2023) 0.01 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 1.65 (07.06.2023) 0.61 %
Aurora Cannabis Inc.
ACB 0.536 (07.06.2023) -0.67 %
Becton Dickinson and Company
BDX 252.23 (07.06.2023) 0.71 %
Biogen Inc.
BIIB 304.9 (07.06.2023) 1.70 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 22.63 (06.06.2023) 4.53 %
BioNTech SE
BNTX 109.41 (07.06.2023) -0.40 %
bluebird bio, Inc.
BLUE 3.72 (07.06.2023) -0.27 %
Boston Scientific Corp.
BSX 50.7 (07.06.2023) 0.06 %
Bristol-Myers Squibb Company
BMY 65.16 (07.06.2023) -0.49 %
Canopy Growth Corp.
CGC 0.7227 (07.06.2023) -2.26 %
Castle Biosciences, Inc.
CSTL 14.91 (07.06.2023) 1.29 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 242.27 (04.02.2022) 0.00 %
Emergent BioSolutions Inc.
EBS 8.5 (07.06.2023) 6.12 %
Exelixis, Inc.
EXEL 18.56 (17.06.2022) 5.63 %
G1 Therapeutics, Inc.
GTHX 2.85 (07.06.2023) 1.79 %
Gilead Sciences, Inc.
GILD 76.08 (07.06.2023) -0.16 %
GlaxoSmithKline plc
GSK 34.36 (07.06.2023) -0.75 %
GoodRx Holdings, Inc.
GDRX 5.41 (07.06.2023) -2.17 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 61.39 (07.06.2023) -0.52 %
Inovio Pharmaceuticals, Inc.
INO 0.5812 (07.06.2023) 3.05 %
Johnson & Johnson
JNJ 166.11 (13.04.2023) 1.34 %
Medtronic plc.
MDT 82.89 (07.06.2023) -0.85 %
Merck & Co., Inc.
MRK 108.61 (07.06.2023) -1.27 %
Moderna, Inc.
MRNA 125.61 (07.06.2023) -1.02 %
Novartis AG
NVS 98.5 (07.06.2023) -1.16 %
Novavax, Inc.
NVAX 7.67 (07.06.2023) 6.09 %
ObsEva SA
OBSV 0.084 (12.05.2023) 0.00 %
OrganiGram Holdings Inc.
OGI 0.4275 (07.06.2023) 1.86 %
Pfizer Inc.
PFE 38.89 (07.06.2023) 1.36 %
Regeneron Pharmaceuticals, Inc.
REGN 738.63 (07.06.2023) -1.27 %
Sanofi
SNY 50.88 (07.06.2023) -1.18 %
Schrodinger, Inc.
SDGR 36.99 (07.06.2023) -3.02 %
Senseonics Holdings, Inc.
SENS 0.7438 (07.06.2023) -5.43 %
Sorrento Therapeutics, Inc.
SRNE 0.33 (06.06.2023) 4.17 %
Stryker Corp.
SYK 277.97 (07.06.2023) 0.51 %
Sundial Growers Inc.
SNDL 1.48 (07.06.2023) 0.00 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 7.38 (07.06.2023) 2.07 %
Thermo Fisher Scientific Inc.
TMO 520.78 (07.06.2023) 0.88 %
Tilray, Inc.
TLRY 1.73 (07.06.2023) -2.26 %
UnitedHealth Group, Inc.
UNH 482.13 (07.06.2023) -1.12 %
Veeva Systems Inc.
VEEV 188.88 (07.06.2023) -3.62 %
Zomedica Corp.
ZOM 0.194 (07.06.2023) -0.26 %
Zynerba Pharmaceuticals, Inc.
ZYNE 0.36 (07.06.2023) 8.24 %

Warning: include(include/reklama_bottom.php): failed to open stream: No such file or directory in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808 Warning: include(): Failed opening 'include/reklama_bottom.php' for inclusion (include_path='.:') in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808

Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.